RT Journal Article
SR Electronic
T1 Disentangling Increased Testing from Covid-19 Epidemic Spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.09.20141762
DO 10.1101/2020.07.09.20141762
A1 Benjamin Lengerich
A1 Willie Neiswanger
A1 Eugene J. Lengerich
A1 Eric P. Xing
YR 2020
UL http://medrxiv.org/content/early/2020/07/10/2020.07.09.20141762.abstract
AB To design effective disease control strategies, it is critical to understand the incidence of diseases. In the Covid-19 epidemic in the United States (caused by outbreak of the SARS-CoV-2 virus), testing capacity was initially very limited and has been increasing at the same time as the virus has been spreading. When estimating the incidence, it can be difficult to distinguish whether increased numbers of positive tests stem from increases in the spread of the virus or increases in testing. This has made it very difficult to identify locations in which the epidemic poses the largest public health risks. Here, we use a probabilistic model to quantify beliefs about testing strategies and understand implications regarding incidence. We apply this model to estimate the incidence in each state of the United States, and find that: (1) the Covid-19 epidemic is likely to be more widespread than reported by limited testing, (2) the Covid-19 epidemic growth in the summer months is likely smaller than it was during the spring months, and (3) the regions which are at highest risk of Covid-19 epidemic outbreaks are not always those with the largest number of positive test results.Competing Interest StatementWN and EX are employed by Petuum, Inc.Funding StatementThis work was supported in part by NIH R01GM114311. B.L. was supported in part by the CMLH Fellowship. The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTest count data is collected by the Covid Tracking Project. Python code to reproduce the analysis is available at the following link. https://github.com/blengerich/Covid19-LatentCases